Smith & Nephew (NYSE:SNN) Earns Hold Rating from Canaccord Genuity Group

Smith & Nephew (NYSE:SNN)‘s stock had its “hold” rating reissued by research analysts at Canaccord Genuity Group in a research note issued to investors on Monday,Benzinga reports. They currently have a $27.00 price objective on the medical equipment provider’s stock. Canaccord Genuity Group’s target price would indicate a potential downside of 6.20% from the company’s previous close.

SNN has been the topic of a number of other research reports. StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, February 26th. UBS Group lowered shares of Smith & Nephew from a “buy” rating to a “neutral” rating in a report on Wednesday, March 12th. Four research analysts have rated the stock with a hold rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, Smith & Nephew presently has a consensus rating of “Hold” and a consensus price target of $27.00.

Smith & Nephew Trading Down 0.8 %

Shares of SNN opened at $28.79 on Monday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew has a 52-week low of $23.65 and a 52-week high of $31.72. The firm has a market cap of $12.58 billion, a price-to-earnings ratio of 13.33, a PEG ratio of 1.26 and a beta of 0.83. The business’s fifty day moving average is $26.52 and its 200-day moving average is $27.09.

Institutional Trading of Smith & Nephew

Hedge funds have recently made changes to their positions in the company. Principal Securities Inc. boosted its stake in shares of Smith & Nephew by 87.6% during the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider’s stock valued at $36,000 after purchasing an additional 691 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Smith & Nephew during the fourth quarter valued at about $41,000. National Bank of Canada FI boosted its stake in shares of Smith & Nephew by 36.5% during the fourth quarter. National Bank of Canada FI now owns 1,667 shares of the medical equipment provider’s stock valued at $41,000 after purchasing an additional 446 shares in the last quarter. Hara Capital LLC boosted its stake in shares of Smith & Nephew by 391.4% during the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider’s stock valued at $60,000 after purchasing an additional 1,957 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in shares of Smith & Nephew by 31.8% during the fourth quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock valued at $73,000 after purchasing an additional 718 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.